StonvexLoading…
StonvexStonvexStonvexCore line items from MDV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 |
|---|---|---|---|---|
Revenue | $46.17M | $37.89M | $28.52M | $18.21M |
Operating Income | $4.93M | $-1.53M | $783.91K | $-2.72M |
Net Income | $-3.29M | $-435.50K | $1.74M | $-1.91M |
EPS (Diluted) | $-0.93 | $-0.20 | $0.18 | $-0.25 |
Total Assets | $454.43M | $428.49M | $430.44M | $389.56M |
Total Liabilities | $213.40M | $206.06M | $204.72M | $211.10M |
Cash & Equivalents | $8.61M | $55.97M | $52.30M | $7.87M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 7.49M | 7.54M | 8.76M | 7.63M |